The latest news from oncology events around the world
A new study led by UCLA Health Jonsson Comprehensive Cancer Centre investigators suggests that adding hormone therapy…
New data presented at the 2026 ASCO Gastrointestinal Cancers Symposium (ASCO GI) highlight continued momentum…
Results from a new phase 3 study found that for people with human epidermal growth…
Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease…
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved…
Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether…
Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer…
A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered…
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated…
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative…